TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Array Biopharma Inc (NASDAQ: ARRY) Investor Securities Class Action Lawsuit 11/20/2017

  • If you purchased shares of Array Biopharma Inc (NASDAQ: ARRY), you may have certain options. Please contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Lawsuit Overview

November 24, 2020 - The court granted the defendants' motion to dismiss. June 11, 2018 - A motion to dismiss the amended complaint was filed. April 26, 2018 - An amended complaint was filed. November 20, 2017 - An investor in shares of Array Biopharma Inc (NASDAQ: ARRY) filed a lawsuit in the U.S. District Court for the District of Colorado over alleged violations of Federal Secu...



You must register (for free) or login to view the entire case.

Click here to Sign In or Register (for a free account)

@screen width:
@theme:
@breakpoints:
@layout: